DKK568.50
4.03% yesterday
Copenhagen, Jun 27, 04:59 pm CET
ISIN
DK0060055861
Symbol
CHEMM
Sector

ChemoMetec Stock price

DKK568.50
+42.50 8.08% 1M
+60.50 11.91% 6M
+82.30 16.93% YTD
+271.90 91.67% 1Y
-238.50 29.55% 3Y
+251.50 79.34% 5Y
+552.59 3,473.13% 10Y
+547.79 2,644.83% 20Y
Copenhagen, Closing price Fri, Jun 27 2025
+22.00 4.03%
ISIN
DK0060055861
Symbol
CHEMM
Sector

Key metrics

Basic
Market capitalization
DKK9.5b
Enterprise Value
DKK9.3b
Net debt
DKK-257.0m
Cash
DKK264.7m
Shares outstanding
17.4m
Valuation (TTM | estimate)
P/E
58.49 | 48.16
P/S
20.70 | 18.63
EV/Sales
20.14 | 18.13
EV/FCF
72.19
P/B
16.54
Dividends
DPS
DKK4.00
Yield 1Y | 5Y
0.70% | 0.45%
Growth 1Y | 5Y
-33.33% | -10.74%
Payout 1Y | 3Y
51.09% | 36.68%
Increased
0 Years
Financials (TTM | estimate)
Revenue
DKK459.5m | DKK510.4m
EBITDA
DKK228.3m | DKK290.5m
EBIT
DKK210.3m
Net Income
DKK169.1m | DKK205.4m
Free Cash Flow
DKK128.2m
Growth (TTM | estimate)
Revenue
14.44% | 25.13%
EBITDA
14.79% | 56.01%
EBIT
16.57%
Net Income
17.58% | 50.71%
Free Cash Flow
15.04%
Margin (TTM | estimate)
Gross
80.06%
EBITDA
49.68% | 56.91%
EBIT
45.77%
Net
36.79% | 40.24%
Free Cash Flow
27.90%
Financial Health
Equity Ratio
83.54%
Return on Equity
24.11%
ROCE
34.62%
ROIC
46.65%
Debt/Equity
0.01
More
EPS
DKK9.72
FCF per Share
DKK7.37
Short interest
-
Employees
184.00
Rev per Employee
DKK2.22m
Show more

Is ChemoMetec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

ChemoMetec Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a ChemoMetec forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a ChemoMetec forecast:

Buy
91%
Hold
9%

Financial data from ChemoMetec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
460 460
14% 14%
100%
- Direct Costs 92 92
8% 8%
20%
368 368
16% 16%
80%
- Selling and Administrative Expenses 140 140
19% 19%
30%
- Research and Development Expense - -
-
-
228 228
15% 15%
50%
- Depreciation and Amortization 18 18
3% 3%
4%
EBIT (Operating Income) EBIT 210 210
17% 17%
46%
Net Profit 169 169
18% 18%
37%

In millions DKK.

Don't miss a Thing! We will send you all news about ChemoMetec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1977 and is headquartered in Allerod, Denmark.

Head office Denmark
CEO Mr. Behrens
Employees 184
Founded 1997
Website chemometec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today